论文部分内容阅读
目的:探究在胆囊炎的我中心门诊中应用硫酸依替米星的临床应用效果。方法 :2010年1月至2015年12月期间,我中心门诊上接受治疗的胆囊炎患者140例作为研究对象,根据患者在我中心门诊中接受治疗的先后顺序进行分组,其中单号设置为对照组,双号设置为观察组,对照组患者在治疗期间采用亮甲菌素和青霉素联合治疗,观察组患者则采用亮甲菌素联合硫酸依替米星进行治疗,对比两组患者的临床治疗效果。结果 :观察组胆囊炎患者的药物应用治疗有效率90.0%明显高于对照组74.3%,差异显著符合统计学评估标准(P<0.05),同时观察组患者的治疗满意度明显高于对照组,差异显著符合统计学评估标准(P<0.05)。结论 :在胆囊炎的临床治疗中应用硫酸依替米星联合亮甲菌素进行治疗能够显著改善患者的临床病症状况,同时提升治疗满意度,值得在临床治疗中推广应用。
Objective: To explore the clinical application of etimicin sulfate in the center of cholecystitis. METHODS: From January 2010 to December 2015, 140 cases of cholecystitis treated in our outpatient center were divided into groups according to the order in which patients were treated in our clinic. The single number was set as the control Group and double number were set as the observation group. The control group patients were treated with combination of brightlysine and penicillin during the treatment. The patients in the observation group were treated with the light methicillin and etimicin sulfate. The clinical treatment of the two groups was compared effect. Results: The effective rate of drug treatment in patients with cholecystitis in observation group was significantly higher than that in control group (90.0% vs. 74.3%, P <0.05), and the treatment satisfaction in observation group was significantly higher than that in control group The difference was significantly consistent with statistical evaluation criteria (P <0.05). Conclusion: The clinical treatment of cholecystitis with etimicin combined with Bronthosin can significantly improve the clinical symptoms of patients, while improving the satisfaction of treatment, it is worth in the clinical treatment of the promotion and application.